The affirmation is a result of several factors, including SCL Health’s strong operating performance, improving balance sheet metrics, limited capital spending, good market position and favorable service area. Moody’s unfavorably viewed SCL Health’s high leverage, material competition and challenging payer mix.
The outlook is stable, reflecting the health system’s strong operating margins, which will allow the health system to meet debt payment requirements.
More articles on healthcare finance:
For-profit hospital operators by the numbers: A look at HCA, Tenet, CHS, LifePoint and UHS
HCA’s profit jumps 25% to $820M in Q2
CHS sees net loss narrow to $110M, pursues $2B hospital divestiture plan
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
